Cardiovasc Intervent Radiol (2017) 40:1440–1446 DOI 10.1007/s00270-017-1662-9 CLINICAL INVESTIGATION NON-VASCULAR INTERVENTIONS Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study 1 2 2 3 • • • • Gianluigi Patelli Antonio Ranieri Aurelio Paganelli Giovanni Mauri Claudio Maurizio Pacella Received: 18 December 2016 / Accepted: 21 April 2017 / Published online: 4 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract 10,522 ± 3290.5 J, mean hospital stay 1.5 ± 0.4 days, and Purpose To assess the feasibility and safety of transper- mean catheterization time 17.3 ± 10.0 days. At 3 months, ineal laser ablation (TPLA) for treating benign prostatic IPSS improved from 21.9 to 10.7 (P\ 0.001), QoL from hyperplasia (BPH). 4.7 ± 0.6 to 2.1 ± 1.2 (P\ 0.001), Q from 7.6 to 13.3 max Materials and Methods Institutional review board approval mL/s (P = 0.001), PVR from 199.9 ± 147.3to81.5 ± 97.8 was obtained for this prospective non-randomized trial. (P\ 0.001), and mean prostate volume from 69.8 to 54.8 mL Eightteen patients (age 71.7 ± 9.4 years) with urinary (P\ 0.001). symptoms secondary to BPH underwent TPLA under local Conclusions TPLA is
CardioVascular and Interventional Radiology – Springer Journals
Published: May 4, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera